Common Contracts
1 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • May 5th, 2020 • New York
CLINICAL TRIAL AGREEMENT This Clinical Trial Agreement(“Agreement”), dated as of (“Effective Date”), is entered into between Regeneron Pharmaceuticals, Inc., having an address at 777 Old Saw Mill River Road, Tarrytown, NY 10591 United States (“Sponsor”), and Nemocnice Jihlava p.o., having an address at Vrchlickeho 59, 586 33 Jihlava Czech Republic (“Institution”) and XXX, having an address at Nemocnice Jihlava p.o., MS centrum (centrum pro lecbu demyelinizacnich onemocneni), Vrchlickeho 59, 586 33 Jihlava Czech Republic(“Principal Investigator”). The Institution and the Principal Investigator are hereinafter called “Institution/Principal Investigator” when it is intended that they be referred to jointly. WHEREAS, the Sponsor desires to conduct a clinical study (“Study”) of Fasinumab/ REGN475 (“Investigational Drug”) as part of a multi-center study under a protocol entitled “A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of
